alpha-Terpinene is a monoterpene hydrocarbon found in tea tree, marjoram, plai, citrus, oregano, and related essential oils. Public evidence is strong for identity, occurrence, and oxidation chemistry, and there is a modest preclinical literature covering antioxidant behavior, antimicrobial screening, inflammatory signaling, and toxicology. The most important caution is that alpha-terpinene can autoxidize into more sensitizing products, so archive copy should treat it as a real aroma constituent with meaningful safety context rather than a simple benign hydrocarbon.
Chemical identity and composition
PubChem and NIST identify alpha-terpinene as C10H16 with InChIKey YHQGMYUVUMAZJR-UHFFFAOYSA-N and the p-mentha-1,3-diene skeleton. In the archive it is a recurring constituent rather than a trace one, ranging from about 0.64% in thyme-spike-turkey to roughly 9% in several tea tree records, with additional presence in marjoram, plai, tangerine, and distilled lime.
Aroma and practical use
- Use the recorded fresh, terpenic, herbaceous, citrus-leaning, woody descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 1995 tea tree paper reported antimicrobial activity screening for major Melaleuca alternifolia components including alpha-terpinene, with tea tree literature generally finding it less active than terpinen-4-ol but still part of the active profile.
A 1995 tea tree paper reported antimicrobial activity screening for major Melaleuca alternifolia components including alpha-terpinene, with tea tree literature generally finding it less active than terpinen-4-ol but still part of the active profile.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2002 macrophage study reported that among three Magnolia sieboldii flower-oil constituents tested, alpha-terpinene was the most effective at inhibiting nitric oxide and PGE2 production in LPS-stimulated rat peritoneal macrophages.
A 2002 macrophage study reported that among three Magnolia sieboldii flower-oil constituents tested, alpha-terpinene was the most effective at inhibiting nitric oxide and PGE2 production in LPS-stimulated rat peritoneal macrophages.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2004 antioxidant study on Australian tea tree oil reported alpha-terpinene among the strongest antioxidant constituents, with activity ranked ahead of alpha-terpinolene and gamma-terpinene in the tested assays.
A 2004 antioxidant study on Australian tea tree oil reported alpha-terpinene among the strongest antioxidant constituents, with activity ranked ahead of alpha-terpinolene and gamma-terpinene in the tested assays.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2005 Salmonella/microsome assay reported alpha-terpinene as not mutagenic under the tested Ames conditions, which is useful as a limited genotoxicity datapoint rather than a complete safety clearance.
A 2005 Salmonella/microsome assay reported alpha-terpinene as not mutagenic under the tested Ames conditions, which is useful as a limited genotoxicity datapoint rather than a complete safety clearance.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2006 Chem Res Toxicol paper demonstrated that alpha-terpinene can act as a prohapten able to induce contact allergy after metabolic activation, linking its conjugated diene structure to sensitizing epoxide formation.
A 2006 Chem Res Toxicol paper demonstrated that alpha-terpinene can act as a prohapten able to induce contact allergy after metabolic activation, linking its conjugated diene structure to sensitizing epoxide formation.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2012 Chem Res Toxicol paper reported that alpha-terpinene autoxidizes rapidly on air exposure to form skin allergens, reinforcing the importance of freshness and oxidation control in tea tree style materials.
A 2012 Chem Res Toxicol paper reported that alpha-terpinene autoxidizes rapidly on air exposure to form skin allergens, reinforcing the importance of freshness and oxidation control in tea tree style materials.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2016 rat study reported memory deficit and toxic effects after oral alpha-terpinene treatment while also measuring brain ATPase and NTPDase changes, indicating that higher-dose exposure findings are mixed rather than purely beneficial.
A 2016 rat study reported memory deficit and toxic effects after oral alpha-terpinene treatment while also measuring brain ATPase and NTPDase changes, indicating that higher-dose exposure findings are mixed rather than purely beneficial.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
alpha-Terpinene is repeatedly discussed as an oxidation-sensitive fragrance constituent, and the strongest constituent-specific safety concern in this pass is increased sensitization potential after autoxidation.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
Ames data do not support mutagenicity under the tested conditions, but that does not override oxidation, irritation, or dose-related toxicology concerns.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
This pass did not verify a clean constituent-specific IFRA dermal limit or a human clinical safety dossier for isolated alpha-terpinene.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
gamma-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read gamma-Terpinene report →p-CymeneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · antioxidant
No source citation attached.
Read p-Cymene report →p-CymeneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read p-Cymene report →CarvacrolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read Carvacrol report →CarvacrolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Carvacrol report →1,8-cineoleAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro mechanistic · antioxidant
No source citation attached.
Read 1,8-cineole report →How the effects were investigated
radical and singlet oxygen quenching
alpha-Terpinene shows strong oxidation-quenching behavior in chemical systems, including protection against lipid oxidation and singlet-oxygen reactions, which helps explain its role as an antioxidant constituent in tea tree oil.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
metabolic activation to sensitizing epoxides
A contact-allergy study identified alpha-terpinene as a conjugated diene prohapten that can be metabolically activated to reactive epoxides, providing a plausible mechanism for sensitization risk after oxidation or metabolism.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
reduced no and pge2 in activated macrophages
A Magnolia sieboldii constituent paper reported alpha-terpinene as the most effective of three tested compounds at inhibiting NO and PGE2 production in LPS-stimulated macrophages, but this remains a narrow cell-model result.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- No human clinical studies specific to isolated alpha-terpinene were verified in this pass.
- Several beneficial-seeming findings are assay-specific or whole-oil contextual rather than robust purified-compound translational evidence.
- This pass did not verify a constituent-specific IFRA limit, inhalation guideline, or long-term human exposure dataset for oxidized alpha-terpinene.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.